Bacteriophage having bactericidal activity with respect to Actinobacillus pleuropneumoniae
AssigneeIntron Biotechnology, Inc.
InventorsJi Hoon Kim, Tae Gyu Kim, Seong Jun Yoon, Soo Youn Jun, Sang Hyeon Kang, Jung Min Kim, Shuk Ho Kim
Life of this patent
Estimating the term…
Abstract
The present invention relates to a bacteriophage having bactericidal activity against Actinobacillus pleuropneumoniae. Bacteriophage PA1Φ can infect Actinobacillus pleuropneumoniae and kill the same bacteria and is characterized by the genome of 34,553 by represented by SEQ ID NO: 1.
Claims2
A method for treating Actinobacillus pleuropneumoniae infections, comprising administering an isolated bacteriophage PA1Φ deposited under Korean Collection for Type Cultures Accession No. KCTC 11796BP to an animal subject, wherein the said bacteriophage PA1Φ has killing activity against Actinobacillus pleuropneumoniae strains.
Dependencies are inferred from the claim text.